November 2020
Leading Diagnostics Companies Join Forces to Establish the Access to Comprehensive Genomic Profiling Coalition (ACGP)
Seven leading diagnostics companies and laboratory service providers have formed the Access to Comprehensive Genomic Profiling Coalition (ACGP). The goal of the organization is to collectively advocate for appropriate broad U.S. health insurance coverage of comprehensive genomic profiling (CGP) for patients living with advanced cancer. The current members of ACGP are Exact Sciences, Foundation Medicine, Illumina, LabCorp, QIAGEN, Roche Diagnostics, and Thermo Fisher Scientific.
February 2020
Resolution Bioscience and LabCorp Will Collaborate to Commercialize the Resolution ctDx Lung™Liquid Biopsy Assay
March 2019
Be The Match Partners with LabCorp to Help Grow Donor Registry
May 2018
LabCorp to Become a Preferred National Laboratory for Aetna
May 2018
UnitedHealthcare Establishes Long-term Strategic Partnership with LabCorp
January 2018
LabCorp Named to FORTUNE Magazine's 2018 List of ‘World’s Most Admired Companies’
November 2017
LabCorp Announces New Expanded Use for PD-L1 Test with Bristol-Myers Squibb’s OPDIVO®
September 2017
LabCorp Named Among “The World’s Most Innovative Companies” in Forbes’ 2017 Ranking
August 2017
OmniSeq and LabCorp Sign Exclusive Distribution Agreement and Series B Funding Commitment
June 2016
LabCorp Announces Launch of New Companion Diagnostic for Non-Small Cell Lung Cancer
January 2016
LabCorp and Cheeriodicals Spread Cheer to UNC Children’s